Cargando…
Ingenol Mebutate: A Succinct Review of a Succinct Therapy
BACKGROUND: Ingenol mebutate is a newly approved topical field therapy for actinic keratosis (AK). It has a dual mechanism of action comprising of a rapid induction of necrosis that specifically targets dysplastic cells, as well as neutrophil-mediated immunostimulatory effects. Such a dual mechanism...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257954/ https://www.ncbi.nlm.nih.gov/pubmed/25159813 http://dx.doi.org/10.1007/s13555-014-0061-2 |